A newly built wharf at the Port of Taichung is to be used to import and export equipment for offshore wind parks, Taiwan International Ports Corp (TIPC) said on Friday.
As the port in Taichung was designated by the Executive Yuan as the basis for the offshore wind energy industry, the company said it is renovating wharves 2, 5A, 5B and 36 and has built a new wharf 106 to facilitate manufacturing, storage, assembly and transport of wind turbine components.
The newly built structure, which was completed in April, also includes a multipurpose yard to accommodate bulk-cargo handling, the company’s chief secretary Wang Kuo-ying (王國瑛) said.
The wharf is 450m in length and 33m wide, and has an operating water depth of 16.3m, Wang said, adding that building costs topped NT$1.186 billion (US$ 39.85 million).
The company has also reinforced the seabed behind the wharf to enable turbine-installation vessels to anchor there, Wang said.
While the renovation of wharf 2 was completed in 2018, renovations of wharves 5A and 5B were completed in the past few weeks, but authorities have not yet inspected them, Wang said
All five wharves are to be put into service by the end of the year, Wang said.
“We hope that all facilities will help to accomplish the goal set by the Executive Yuan, which is to generate 5.7 gigawatts of clean wind energy by 2025,” Wang added.
While the antiparasitic drug ivermectin is being touted as a treatment for COVID-19 in many parts of the world, Taiwanese experts on Monday warned against regular use of the drug in COVID-19 treatment, citing a lack of solid evidence. “Following an experts’ meeting, we do not recommend regular use of ivermectin in treating COVID-19 due to the lack of enough evidence,” said Chang Shan-chwen (張上淳), convener of the Central Epidemic Command Center’s (CECC) expert advisory panel. A report in the American Journal of Therapeutics said that meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID-19 patients had found large,
CLASSES HALTED: Cram schools have had to return tuition fees due to mandatory closures and might need to lay off half of their staff because of a lack of revenue The COVID-19 pandemic has taken a toll on the education sector, with some cram schools and tutoring centers saying they might soon be unable to pay their instructors due to the extension of a nationwide level 3 COVID-19 alert. The heightened alert level means schools must remain closed, so cram schools and tutoring centers have had to return tuition fees, one cram school said. June is normally the peak season for recruiting new students at cram schools and tutoring centers, but this year many such schools might need to lay off half of their staff due to a lack of
A person who was on Friday reported as the first in Taiwan to die after receiving a COVID-19 vaccine died of a heart attack, a Central Epidemic Command Center (CECC) official said yesterday. The deceased, whose sex and age were not disclosed, had coronary artery disease, which led to a fatal heart attack, Centers for Disease Control Deputy Director-General Chuang Jen-hsiang (莊人祥), who is the CECC’s spokesman, told a news conference, citing the autopsy report. It was the first death listed as a possible adverse event after receiving the AstraZenenca COVID-19 vaccine since the start of the vaccination program on March 22. The
PARTY LINES: Just 28.1% of respondents said they were willing to get a local vaccine, including 52.8% of DPP voters and 48.6% of Taiwan Statebuilding Party voters Sixty-two percent of Taiwanese disapprove of the Central Epidemic Command Center’s (CECC) progress in obtaining COVID-19 vaccines, while 65.6 percent said that they would not take domestic vaccines that lack WHO certification, a poll released yesterday by Trend Survey and Research and commissioned by the Taiwan People’s Party (TPP) found. Trend Survey general manager Wu Shih-chang (吳世昌) announced the results of the survey with TPP officials at a virtual news conference, adding that 41.3 percent of respondents said that they highly disapproved of the center’s efforts to secure vaccines. About 68.6 percent of the respondents agreed that the country should rely on